A carregar...
Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial
BACKGROUND: High blood pressure (BP) is a common chronic disease needs long life drug consumption to control. Spironolactone could be used as the fourth-line therapy in patients with resistant hypertension. However, there is no study to determine the effects of low dose spironolactone as a first lin...
Na minha lista:
| Publicado no: | Acta Cardiol Sin |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taiwan Society of Cardiology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777944/ https://ncbi.nlm.nih.gov/pubmed/29375225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS.201801_34(1).20170903B |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|